Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
24.26
-0.10 (-0.41%)
Oct 7, 2026, 4:00 PM EDT - Market closed
Xencor Employees
Xencor had 260 employees as of December 31, 2025. The number of employees increased by 10 or 4.00% compared to the previous year. That makes Xencor the world's 24,895th largest employer and 3,205th in the United States.
Employees
260
Change (1Y)
10
Growth (1Y)
4.00%
Revenue / Employee
$403,742
Profits / Employee
-$628,173
Market Cap
1.80B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 260 | 10 | 4.00% | 260 | 0 |
| Dec 31, 2024 | 250 | -30 | -10.71% | 250 | 0 |
| Dec 31, 2023 | 280 | -1 | -0.36% | 280 | 0 |
| Dec 31, 2022 | 281 | 27 | 10.63% | 281 | 0 |
| Dec 31, 2021 | 254 | 52 | 25.74% | 254 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Novavax | 749 |
| Agios Pharmaceuticals | 540 |
| Structure Therapeutics | 281 |
| Biohaven | 274 |
| Zymeworks | 231 |
| Zenas BioPharma | 167 |
| Mesoblast | 108 |
XNCR News
- 16 days ago - Xencor price target raised to $26 from $20 at BofA - TheFly
- 26 days ago - Xencor price target raised to $35 from $27 at Barclays - TheFly
- 4 weeks ago - Xencor Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 4 weeks ago - Xencor Slides: Corporate presentation - Filings
- 4 weeks ago - Xencor price target raised to $21 from $14 at JPMorgan - TheFly
- 5 weeks ago - Xencor to Present at the 2026 Cantor Global Healthcare Conference - Business Wire
- 5 weeks ago - Xencor price target raised to $46 from $40 at Raymond James - TheFly
- 2 months ago - Xencor price target raised to $30 from $26 at Wedbush - TheFly